Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells.
about
MicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsGlioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic TargetsMicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cellsThe evolving landscape of glioblastoma stem cells.G protein-coupled receptor 87 (GPR87) promotes the growth and metastasis of CD133⁺ cancer stem-like cells in hepatocellular carcinomaSilencing of reversion-inducing cysteine-rich protein with Kazal motifs stimulates hyperplastic phenotypes through activation of epidermal growth factor receptor and hypoxia-inducible factor-2α.Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.Compound 331 selectively induces glioma cell death by upregulating miR-494 and downregulating CDC20.Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.CD133: a stem cell biomarker and beyondRole of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors.New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.MicroRNAs in the Regulation of MMPs and Metastasis.Stem cells and gliomas: past, present, and future.MiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cells.miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3.MicroRNA-125b inhibitor sensitizes human primary glioblastoma cells to chemotherapeutic drug temozolomide on invasion.Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1.Cell Cycle Regulation of Stem Cells by MicroRNAs.MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme.miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.
P2860
Q26747273-E21346AD-3B68-4627-9BAA-6CBA4B5930CAQ26765758-D74B5379-E2DF-416B-AA11-76B41BB234AAQ26865287-DDA4CEEA-05B9-4964-B316-26D6C96142E0Q33652614-7425CC86-6C79-472B-8C37-E5E974DAC29CQ34674548-5522460F-8CEB-4EEC-A51B-B1056E84F2E0Q35078415-981237EE-542C-41B3-B0EB-E570D0C17963Q35589764-E7BFAD8A-DCAD-41C2-852B-5AF708C8529BQ35830062-145645E5-B874-4E3A-9685-63AC685C01C7Q36129189-82719967-E9BA-401E-866F-DD4AB0F19A35Q36982860-677CC999-159F-4F25-8F40-B775C97197E2Q37540188-CF7A9629-6D31-4038-A74A-4D934AE9E44FQ38174477-CAC6C5AA-A26F-4A5E-BE95-6884BAB73BB0Q38199556-E528FE35-4EAC-4EC2-B629-9DEE4B34988CQ38235856-91A6581B-5FCE-4493-BD08-16FABF9FEADCQ38978071-0103D374-35A4-4024-9388-36F256E66372Q39125450-CD5D3B60-5D37-4477-91FB-268D80ED6542Q39128804-0304CB9D-4B05-4B04-BE04-081B0F583325Q42619165-12666ADC-2E79-4E93-9F2F-9FDF2B7F9B34Q45044001-07674621-644C-4286-A84A-026D6BEA9D63Q52726443-4DB18669-0278-46E9-A62A-0A46D100AFA7Q55460933-E0830715-F4AF-474F-A267-E9B11B990056Q55460959-235C7272-E0FF-4A78-8F54-0A2DB9D2CDEF
P2860
Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Functional differences of miR- ...... ells and CD133-positive cells.
@en
Functional differences of miR- ...... ells and CD133-positive cells.
@nl
type
label
Functional differences of miR- ...... ells and CD133-positive cells.
@en
Functional differences of miR- ...... ells and CD133-positive cells.
@nl
prefLabel
Functional differences of miR- ...... ells and CD133-positive cells.
@en
Functional differences of miR- ...... ells and CD133-positive cells.
@nl
P2093
P2860
P1476
Functional differences of miR- ...... ells and CD133-positive cells.
@en
P2093
Chunfa Qian
Shuguang Zhang
Tianhong Pan
Xiaoyan Gu
Yongping You
Zhimin Wang
P2860
P2888
P304
P356
10.1007/S12017-012-8188-8
P577
2012-06-19T00:00:00Z